Literature DB >> 15001841

Uncharged P-selectin blockers.

T V Pochechueva1, O E Galanina, N A Ushakova, M E Preobrazhenskaya, M A Sablina, N E Nifantiev, Yu V Tsvetkov, Ya V Vozney, A Imberty, N V Bovin.   

Abstract

The blocking potency of P- and L-selectin was studied for certain small molecule mannosides and their polyacrylamide (PAA, 30 kDa) conjugates in comparison to SiaLe(x) and fucoidan. Two experimental systems were used: (1) solid phase static assay based on recombinant selectins, and (2) P-selectin dependent rat peritoneal inflammation. betaMan-SC6H4NO2- p was four times more potent P-selectin inhibitor as compared to SiaLe(x). Docking of this molecule onto the P-selectin carbohydrate-binding site demonstrated that a nitro group enabled an electrostatic interaction with residue Lys 84, while the phenyl ring and the CH2 at C-6 contacted the CH2 groups of the same Lys residue. In vivo, betaMan-SC6H4NO2- p blocked experimental inflammation better than SiaLe(x), but significantly lower than fucoidan. In vitro Man-polyacrylic acid conjugates appeared to be very potent inhibitors comparable to fucoidan, uncharged Man-PAA proved rather active, comparable to SiaLe(x)-PAA both in vitro, and in vivo, whereas mannan did not display any P-selectin blocking effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001841     DOI: 10.1023/B:GLYC.0000018583.63140.91

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  19 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1.

Authors:  W S Somers; J Tang; G D Shaw; R T Camphausen
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

3.  Selectinminus signCarbohydrate Interactions: From Natural Ligands to Designed Mimics.

Authors:  Eric E. Simanek; Glenn J. McGarvey; Jill A. Jablonowski; Chi-Huey Wong
Journal:  Chem Rev       Date:  1998-04-02       Impact factor: 60.622

4.  Protective effects of oligosaccharides in P-selectin-dependent lung injury.

Authors:  M S Mulligan; J C Paulson; S De Frees; Z L Zheng; J B Lowe; P A Ward
Journal:  Nature       Date:  1993-07-08       Impact factor: 49.962

5.  Mechanism of ligand binding to E- and P-selectin analyzed using selectin/mannose-binding protein chimeras.

Authors:  D Torgersen; N P Mullin; K Drickamer
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

6.  Fucoidan inhibits leukocyte recruitment in a model peritoneal inflammation in rat and blocks interaction of P-selectin with its carbohydrate ligand.

Authors:  M E Preobrazhenskaya; A E Berman; V I Mikhailov; N A Ushakova; A V Mazurov; A V Semenov; A I Usov; N E Nifant'ev; N V Bovin
Journal:  Biochem Mol Biol Int       Date:  1997-10

7.  Scintillation proximity assay for E-, P-, and L-selectin utilizing polyacrylamide-based neoglycoconjugates as ligands.

Authors:  S M Game; P K Rajapurohit; M Clifford; M I Bird; R Priest; N V Bovin; N E Nifant'ev; G O'Beirne; N D Cook
Journal:  Anal Biochem       Date:  1998-04-10       Impact factor: 3.365

8.  Interaction of P-selectin (CD62) and its cellular ligand: analysis of critical residues.

Authors:  D Hollenbaugh; J Bajorath; R Stenkamp; A Aruffo
Journal:  Biochemistry       Date:  1993-03-30       Impact factor: 3.162

9.  Assembly of p-selectin ligands on a polymeric template.

Authors:  Tatyana V Pochechueva; Oxana E Galanina; Michael I Bird; Nikolay E Nifantiev; Nicolai V Bovin
Journal:  Chem Biol       Date:  2002-06

10.  Possible role for cell-surface carbohydrate-binding molecules in lymphocyte recirculation.

Authors:  L M Stoolman; S D Rosen
Journal:  J Cell Biol       Date:  1983-03       Impact factor: 10.539

View more
  2 in total

Review 1.  Endothelial Cell Adhesion Molecules- (un)Attainable Targets for Nanomedicines.

Authors:  Nenad Milošević; Marie Rütter; Ayelet David
Journal:  Front Med Technol       Date:  2022-04-07

Review 2.  Polysaccharide nanosystems for future progress in cardiovascular pathologies.

Authors:  Amanda Karine Andriola Silva; Didier Letourneur; Cédric Chauvierre
Journal:  Theranostics       Date:  2014-03-11       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.